Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up
American Journal of Hematology, 05/16/2012
Zuckerman T et al. – The risk–adapted approach using only partial T cell depletion (TCD) and preemptive escalated dose of donor lymphocyte infusion (DLI) precluded the need for immunosuppressive medications and reduced the risk of significant graft–versus–host disease (GvHD) without compromising engraftment and long–term disease control.
